Sign in
CompletedNo phase

Fetal Cardiac Function

Key facts

Who runs it
Assiut University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
72 people enrolled
Started
30 Apr 2024
Ended
12 Dec 2024
Type of study
Observational, 2 groups
Treatments tested
  • Ultrasound
Record updated
24 December 2024

Who can take part

Sex
Women only
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Pregnant women more than or equals 28 weeks
  • Preeclampsia defined as systolic blood pressure 140 mm Hg and/or diastolic blood pressure 90 mm Hg
  • Fetus with normal growth or with growth restriction

Who cannot take part

  • fetuses of mothers treated with a tocolytic agent
  • intrauterine infection
  • fetuses with abnormal heart rates (tachycardia or bradycardia)
  • congenital malformations
  • multiple pregnancies

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of our study is to evaluate the effect of PE and FGR on fetal cardiac function. Pregnancies with preeclampsia and FGR, and preeclampsia with normal fetal growth are evaluated by echocardiography and compared with uncomplicated pregnancies.

The 2 groups in the trial

  • Patients with preeclampsia

    Fetal ultrasound( echocardiography).Measurements will be performed using conventional pulsed-wave Doppler and M mode cross sectional image of the fetal thorax at the level of the 4-chamber view with an apical projection of the heart is obtained. Measurements of the ventricle at diastole and systole are obtained, and using the relationship between these measurements, calculations are performed to determine the ejection fraction (EF) (\[diastole measurement-systole measurement\]/diastole) measurement and shortening fraction ( SF) for both right \& left ventricles. Assessment of ventricular diastolic function through measuring E-wave (early ventricular filling) and A wave (active atrial contraction - late ventricular filling) peak velocities and the ratio between them (E/A ratio) as an index will be performed for both mitral valve (MV) and tricuspid valve (TV)

    Treatment: Ultrasound

  • Patients without preeclampsia

    Fetal ultrasound (echocardiography).Measurements will be performed using conventional pulsed-wave Doppler and M mode cross sectional image of the fetal thorax at the level of the 4-chamber view with an apical projection of the heart is obtained. Measurements of the ventricle at diastole and systole are obtained, and using the relationship between these measurements, calculations are performed to determine the ejection fraction (EF) (\[diastole measurement-systole measurement\]/diastole) measurement and shortening fraction ( SF) for both right \& left ventricles. Assessment of ventricular diastolic function through measuring E-wave (early ventricular filling) and A wave (active atrial contraction - late ventricular filling) peak velocities and the ratio between them (E/A ratio) as an index will be performed for both MV and TV

    Treatment: Ultrasound

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Fetal Systolic and Diastolic Cardiac Function Assessment in Mothers with Preeclampsia
Record updated
24 December 2024